TrialBMC cancer2012

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study.

Carolyn D Britten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.